Memantine Extended-Release Capsules and Moxetumomab pasudotox
Determining the interaction of Memantine Extended-Release Capsules and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: memantine
Brand name: Namenda, Namenda XR
Synonyms: Memantine
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Memantine Extended-Release Capsules-Moxetumomab Pasudotox-tdfk
- Memantine Extended-Release Capsules-Moxetumomab pasudotox-tdfk Intravenous
- Memantine Extended-Release Capsules-Moxifloxacin
- Memantine Extended-Release Capsules-Moxifloxacin (Systemic)
- Memantine Extended-Release Capsules-Moxifloxacin Hydrochloride
- Memantine Extended-Release Capsules-Moxifloxacin Injection
- Moxetumomab pasudotox-Memantine Hydrochloride
- Moxetumomab pasudotox-Memantine Oral Solution
- Moxetumomab pasudotox-Memantine Solution
- Moxetumomab pasudotox-Memantine Tablets
- Moxetumomab pasudotox-Members Mark Cetirizine
- Moxetumomab pasudotox-Members Mark Loratadine